Modeling the Insulin-Like Growth Factor System in Articular Cartilage

PLoS ONE

Volumn 8, Issue 6, 2013, Pages

  Zhang, Lihai ^a   Smith, David W ^b   Gardiner, Bruce S ^b   Grodzinsky, Alan J ^c  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^c USA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEINASE; SOMATOMEDIN; SOMATOMEDIN B; SOMATOMEDIN B RECEPTOR; SOMATOMEDIN BINDING PROTEIN; SOMATOMEDIN C; SOMATOMEDIN C RECEPTOR; INSULIN;

ARTICLE; ARTICULAR CARTILAGE; CLEARANCE; COMPLEX FORMATION; CONCENTRATION (PARAMETERS); EXTRACELLULAR MATRIX; HALF LIFE TIME; MATHEMATICAL COMPUTING; MATHEMATICAL MODEL; PROTEIN DEGRADATION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; BIOLOGICAL MODEL; CYTOLOGY; HOMEOSTASIS; HUMAN; METABOLISM;

CARTILAGE, ARTICULAR; HOMEOSTASIS; HUMANS; INSULIN; INSULIN-LIKE GROWTH FACTOR I; INSULIN-LIKE GROWTH FACTOR II; MODELS, BIOLOGICAL; SIGNAL TRANSDUCTION;

EID: 84879478714     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0066870     Document Type: Article

References (77)

1. Durai R, Yang W, Gupta S, Seifalian AM, Winslet MC, (2005) The role of the insulin-like growth factor system in colorectal cancer: review of current knowledge International Journal of Colorectal Disease. 20: 203-220.
2. Velloso CP, (2008) Regulation of muscle mass by growth hormone and IGF-I. British Journal of Rheumatology 154: 557-568.
3. Mohan S, Baylink DJ, (2002) IGF-binding proteins are multifunctional and act via IGF-dependent and-independent mechanisms. Journal of Endocrinology 175: 19-31.
4. D'Ercole AJ, Ye P, (2008) Expanding the mind: IGF-I and brain development Endocrinology. 149: 5958-5962.
5. Foulstone E, Prince S, Zaccheo O, Burns JL, Harper J, et al. (2005) Insulin-like growth factor ligands, receptors, and binding proteins in cancer. Journal of Pathology 205: 145-153.
6. Chernausek SD, Backeljauw PF, Frane J, Kuntze J, Underwood LE, (2007) Long-Term Treatment with Recombinant Insulin-Like Growth Factor (IGF)-I in Children with Severe IGF-I Deficiency due to Growth Hormone Insensitivity. The Journal of Clinical Endocrinology & Metabolism 92: 902-910.
7. Juul A, (2003) Serum levels of insulin-like growth factors I and its binding proteins in health and disease. Growth Hormone & IGF Research 13: 113-170.
8. Renehan AG, Zwahlen M, Minder C, O'Dwyer ST, Shalet SM, et al. (2004) Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysis. The Lancet 363: 1346-1353.
9. Hankinson SE, Willett WC, Colditz GA, Hunter DJ, Michaud DS, et al. (1998) Circulating concentrations of insulin-like growth factor I and risk of breast cancer. The Lancet 351: 1393-1396.
10. Pollak M, (2000) Insulin-like growth factor physiology and cancer risk. European Journal of Cancer 36: 1224-1228.
11. Benini S, Zuntini M, Manara MC, Cohen P, Nicoletti G, et al. (2006) Insulin-like growth factor binding protein 3 as an anticancer molecule in Ewing's sarcoma. International Journal of Cancer 119: 1039-1046.
12. Scotlandi K, (2006) Targeted therapies in Ewing's sarcoma. Advances in Experimental Medicine and Biology 587: 13-22.
13. Manara MC, Landuzzi L, Nanni P, Nicoletti G, Zambelli D, et al. (2007) Preclinical in vivo study of new insulin-like growth factor-I receptor-specific inhibitor in Ewing's sarcoma Clinical Cancer Research. 13: 1322-1330.
14. Samani AA, Yakar S, LeRoith D, Brodt P, (2007) The role of the IGF system in cancer growth and metastasis: Overview and recent Insights Endocrine Reviews. 28: 20-47.
15. Baserga R, Peruzzi F, Reiss K, (2003) The IGF-1 receptor in cancer biology. International Journal of Cancer 107: 873-877.
16. Olmos D, Postel-Vinay S, Molife LR, Okuno SH, Schuetze SM, et al. (2010) Safety, pharmacokinetics, and preliminary activity of the anti-IGF-1R antibody figitumumab (CP-751,871) in patients with sarcoma and Ewing's sarcoma: a phase 1 expansion cohort study The Lancet Oncology. 11: 129-135.
17. Allison M, (2012) Clinical setbacks reduce IGF-1 inhibitors to cocktail mixers. Nature Biotechnology 30: 906-907.
18. Zhang L, Gardiner BS, Smith DW, Pivonka P, Grodzinsky AJ, (2009) Integrated model of IGF-I mediated biosynthesis in deforming articular cartilage. Journal of Engineering Mechanics 135: 439-449.
19. Zhang L, Gardiner BS, Smith DW, Pivonka P, Grodzinsky AJ, (2008) A fully coupled poroelastic reactive-transport model of cartilage. Molecular & Cellular Biomechanics 5: 133-153.
20. Yu H, Rohan T, (2000) Role of the Insulin-Like Growth Factor Family in Cancer Development and Progression. Journal of the National Cancer Institute 92: 1472-1489.
21. Wilson EM, Rotwein P, (2006) Control of MyoD Function during Initiation of Muscle Differentiation by an Autocrine Signaling Pathway Activated by Insulin-like Growth Factor-II. The Journal of Biological Chemistry 281: 29962-29971.
22. Barta E, Maroudas A, (2006) A theoretical study of the distribution of insulin-like growth factor in human articular cartilage. Journal of Theoretical Biology 241: 628-638.
23. Wang HS, Chard T, (1999) IGFs and IGF-binding proteins in the regulation of human ovarian and endometrial function. Journal of Endocrinology 161: 1-13.
24. Chu CH, Tzang BS, Chen LM, Liu CJ, Tsai FJ, et al. (2009) Activation of Insulin-Like Growth Factor II receptor induces mitochondrial-dependent apoptosis through G-alpha-q and downstream calcineurin signaling in myocardial cells. Endocrinology 150: 2723-2731.
25. LeRoith D, Roberts CT, (2003) The insulin-like growth factor system and cancer Cancer Letters. 195: 127-137.
26. Tavera C, Abribat T, Reboul P, Dore S, Brazeau P, et al. (1996) IGF and IGF-binding protein system in the synovial fluid of osteoarthritic and rheumatoid arthritic patients. Osteoarthritis and Cartilage 4: 263-274.
27. Lambert S, Gol-Winkler R, Collette J, Gillis J, Franchimont P, et al. (2006) Tumor IGF-II content in a patient with a colon adenocarcinoma correlates with abnormal expression of the gene. International Journal of Cancer 48: 826-830.
28. Bach LA, Headey SJ, Norton RS, (2005) IGF-binding proteins - the pieces are falling into place. Trends in Endocrinology & Metabolism 16: 228-234.
29. Paye JMD, Forsten-Williams K, (2006) Regulation of insulin-like growth factor-I (IGF-I) delivery by IGF binding proteins and receptors. Annals of Biomedical Engineering 34: 618-632.
30. Rajaram S, Baylink DJ, Mohan S, (1997) Insulin-Like Growth Factor-Binding Proteins in Serum and Other Biological Fluids: Regulation and Functions. Endocrine Reviews 18: 801-831.
31. Oh Y, Nagalla SR, Yamanaka Y, Kim HS, Wilson E, et al. (1996) Synthesis and characterization of insulin-like growth factorbinding protein (IGFBP)-7. Recombinant human mac25 protein specifically binds IGF-1 and-II. Journal of Biological Chemistry 271: 30322-30325.
32. Jones JI, Clemmons DR, (1995) Insulin-like Growth Factors and their binding proteins: biological actions. Endocrine Reviews 16: 3-34.
33. Zhang L, Gardiner BS, Smith DW, Pivonka P, Grodzinsky AJ, (2010) On the role of diffusible binding partners in modulating the transport and concentration of proteins in tissues. Journal of Theoretical Biology 263: 20-29.
34. Bunn RC, Fowlkes JL, (2003) Insulin-like growth factor binding protein proteolysis Trends in Endocrinology & Metabolism. 14: 176-181.
35. Busby WH, Nam TJ, Moralez A, Smith C, Jennings M, et al. (2000) The complement component C1s is the protease that accounts for cleavage of insulin-like growth factor-binding protein-5 in fibroblast medium. Journal of Biological Chemistry 275: 37638.
36. Loechel F, Fox JW, G GM, Albrechtsen R, Wewer UM, (2000) ADAM 12-S cleaves IGFBP-3 and IGFBP-5 and is inhibited by TIMP-3. Biochemical and Biophysical Research Communications 278: 511-515.
37. Nagase H, Visse R, Murphy G, (2006) Structure and function of matrix metalloproteinases and TIMPs. Cardiovascular Research 60: 562-573.
38. Marinaro JA, Casley DJ, Bach LA, (2000) O-glycosylation delays the clearance of human IGF-binding protein-6 from the circulation. European Journal of Endocrinology 142: 512-516.
39. Grimberg A, Cohen P, (2000) Role of insulin-like growth factors and their binding proteins in growth control and carcinogenesis. Journal of Cellular Physiology 183: 1-9.
40. Heding A, Gill R, Ogawa Y, Meyts PD, Shymko RM, (1996) Biosensor Measurement of the Binding of Insulin-like Growth Factors I and II and Their Analogues to the Insulin-like Growth Factor-binding Protein-3. The Journal of Biological Chemistry 271: 13948-13952.
41. Headey SJ, Leeding KS, Norton RS, Bach LA, (2004) Contributions of the N- and C-terminal domains of IGF binding protein-6 to IGF binding. Journal of Molecular Endocrinology 33: 377-386.
42. Vorwerk P, Hohmann B, Oh Y, Rosenfeld RG, Shymko RM, (2002) Binding Properties of Insulin-Like Growth Factor Binding Protein-3 (IGFBP-3), IGFBP-3 N- and C-Terminal Fragments, and Structurally Related Proteins mac25 and Connective Tissue Growth Factor Measured Using a Biosensor. Endocrinology 143: 1677-1685.
43. Zhang L, Gardiner BS, Smith DW, Pivonka P, Grodzinsky AJ, (2008) IGF uptake with competitive binding in articular cartilage. Journal of Biological Systems 16: 175-195.
44. Bhakta NR, Garcia AM, Frank EH, Grodzinsky AJ, Morales TI, (2000) The Insulin-like Growth Factors (IGFs) I and II Bind to Articular Cartilage via the IGF-binding Proteins. The Journal of Biological Chemistry 275: 5860-5866.
45. Yamanaka Y, Wilson EM, Rosenfeld RG, Oh Y, (1997) Inhibition of insulin receptor activation by insulin-like growth factor binding proteins. The Journal of Biological Chemistry 272: 30729-30734.
46. Martel-Pelletier J, Battista JAD, Lajeunesse D, Pelletier J-P, (1998) IGF/IGFBP axis in cartilage and bone in osteoarthritis pathogenesis Inflammation Research. 47: 90-100.
47. Blakesley VA, Scrimgeour A, Esposito D, Roith DL, (1996) Signaling via the insulin-like growth factor-I receptor: Does it differ from insulin receptor signaling? Cytokine & Growth Factor Reviews 7: 153-159.
48. Slaaby R, Schäffer L, Lautrup-Larsen I, Andersen AS, Shaw AC, et al. (2006) Hybrid receptors formed by Insulin Receptor (IR) and Insulin-like Growth Factor I Receptor (IGF-IR) have low Insulin and high IGF-1 affinity irrespective of the IR splice variant. Journal of Biological Chemistry 281: 25869-25874.
49. Gardiner BS, Smith DW, Pivonka P, Grodzinsky AJ, Frank EH, et al. (2007) Solute transport in cartilage undergoing cyclic deformation. Computer Methods in Biomechanics and Biomedical Engineering 10: 265-278.
50. Zhang L, Gardiner BS, Smith DW, Pivonka P, Grodzinsky AJ, (2007) The effect of cyclic deformation and solute binding on solute transport in cartilage. Archives of Biochemistry and Biophysics 457: 47-56.
51. Zhang L, Gardiner BS, Smith DW, Pivonka P, Grodzinsky AJ (2010) The Transport of Insulin-like Growth Factor through Cartilage. In: Vafai K, editor. Porous Media: Applications in Biological Systems and Biotechnology: Taylor & Francis Group.
52. Gardiner BS, Zhang L, Smith DW, Pivonka P, Grodzinsky AJ, (2011) A mathematical model for targeting chemicals to tissues by exploiting complex degradation. Biology Direct 6: 1-16.
53. Zhang L, (2011) Solute transport in cyclic deformed heterogeneous articular cartilage. International Journal of Applied Mechanics 3: 1-18.
54. Eviatar T, Kauffman H, Maroudas A, (2003) Synthesis of Insulin-Like Growth Factor Binding Protein 3 In Vitro in Human Articular Cartilage Cultures. Arthritis & Rheumatism 48: 410-417.
55. Lee AS (1984) Modeling dynamic phenomena in molecular and cellular biology. Cambridge University Press.
56. Stumm S, James JM (1996) Aquatic Chemistry. John Wiley & Sons, Inc.
57. Fong C-C, Wong M-S, Fong W-F, Yang M, (2002) Effect of hydrogel matrix on binding kinetics of protein-protein interactions on sensor surface. Analytica Chimica Acta 456: 201-208.
58. Schneiderman R, Rosenberg N, Hiss J, Lee P, Liu F, et al. (1995) Concentration and size distribution of Insulin-like Growth Factor-I in human normal and osteoarthritic synovial fluid and cartilage. Archives of Biochemistry and Biophysics 324: 173-188.
59. Qiu Y, Tarbell JM, (2000) Numerical Simulation of Oxygen Mass Transfer in a Compliant Curved Tube Model of a Coronary Artery. Annals of Biomedical Engineering 28: 26-38.
60. COMSOL-Multiphysics (2007) MA, USA: COMSOL, Inc.
61. Boden G, Chen X, Kolaczynski JW, Polansky M, (1997) Effects of prolonged hyperinsulinemia on serum leptin in normal human subjects. Journal of Clinical Investigation 100: 1107-1113.
62. Guler H-P, Zapf J, Schmid C, Froesch ER, (1989) Insulin-like growth factors I and II in healthy man. Acta Endocrinologica 121: 753-758.
63. Flessner MF, (1996) Small-solute transport across specific peritoneal tissue surfaces in the rat. Journal of the American Society of Nephrology 7: 225-233.
64. Dowthwaite GP, Bishop JC, Redman SN, Khan IM, Rooney P, et al. (2004) The surface of articular cartilage contains a progenitor cell population. Journal of Cell Science 117: 889-897.
65. Hayes AJ, MacPherson S, Morrison H, Dowthwaite G, Archer CW, (2001) The development of articular cartilage: evidence for an appositional growth mechanism. Anatomy and Embryology 203: 469-479.
66. Sadicka MD, Intintoli A, Quarmby V, McCoy A, Canova-Davisc E, et al. (1999) Kinase receptor activation (KIRA): a rapid and accurate alternative to end-point bioassays. Journal of Pharmaceutical and Biomedical Analysis 19: 883-891.
67. Cai L, Okumu FW, Cleland JL, Beresini M, Hogue D, et al. (2002) A slow release formulation of insulin as a treatment for osteoarthritis. Osteoarthritis and Cartilage 10: 692-706.
68. Bach LA, (1999) Insulin-like growth factor binding protein-6 the "forgotten" binding protein? Hormone and Metabolic Research 31: 226-234.
69. Stoltz JF (2006) Mechanobiology: Cartilage and Chondrocyte. Amsterdam, The Netherlands: IOS Press.
70. Brocklehurst R, Bayliss M, Maroudas A, Coysh H, Freeman M, et al. (1984) The composition of normal and osteoarthritic articular cartilage from human knee joints. With special reference to unicompartmental replacement and osteotomy of the knee. Journal of Bone & Joint Surgery 66: 95-106.
71. Dore S, Pelletier JP, DiBattista JA, Tardif G, Brazeau P, et al. (1994) Human osteoarthritic chondrocytes possess an increased number of insulin-like growth factor 1 binding sites but are unresponsive to its stimulation. Possible role of IGF-1-binding proteins. Arthritis & Rheumatism 37: 253-263.
72. Sessions CM, Emler CA, Schalch DS, (1987) Interaction of Insulin-Like Growth Factor II with Rat Chondrocytes: Receptor Binding, Internalization, and Degradation. Endocrinology 120: 2108-2016.
73. Verschure PJ, Marle J, Joosten LA, Berg WB, (1995) Chondrocyte IGF-1 receptor expression and responsiveness to IGF-1 stimulation in mouse articular cartilage during various phases of experimentally induced arthritis. Annals of the Rheumatic Diseases 54: 645-653.
74. Osipo C, Sara Dorman AF, (2001) Loss of Insulin-like Growth Factor II Receptor Expression Promotes Growth in Cancer by Increasing Intracellular Signaling from both IGF-I and Insulin Receptors. Experimental Cell Research 264: 388-396.
75. Garcia AM, Szasz N, Trippel SB, Morales TI, Grodzinsky AJ, et al. (2003) Transport and binding of insulin-like growth factor I through articular cartilage. Archives of Biochemistry and Biophysics 415: 69-79.
76. Mauck RL, Hung CT, Ateshian GA, (2000) Modeling of neutral solute transport in a dynamically loaded porous permeable gel: implications for articular cartilage biosynthesis and tissue engineering. Journal of Biomechanical Engineering 125: 602-614.
77. Slaaby R, Schaffer L, Lautrup-Larsen I, Andersen AS, Shaw AC, et al. (2006) Hybrid receptors formed by insulin receptor (IR) and insulin-like growth factor I receptor (IGF-IR) have low insulin and high IGF-1 affinity irrespective of the IR splice variant. The Journal of Biological Chemistry 281: 25869-25874.